Estrogen replacement therapy is recommended for the prevention of osteoporosis and the attenuation of symptoms associated with menopause. Compliance may be a problem with sequential regimens of estrogen and progestin. To address this issue, continuous-dosing regimens of estrogen and progestin have been used. These regimens cause significantly less cyclic and intermenstrual bleeding and induce amenorrhea in most women, which should enhance compliance.
|Original language||English (US)|
|Number of pages||5|
|Journal||American family physician|
|State||Published - Dec 14 1994|
ASJC Scopus subject areas
- Family Practice